A Case Report of Bisphosphonate-induced Bilateral Osteoporotic Subtrochanteric Fracture Femurii: Review of Literature

What to Learn from this Article? Long-term treatment with alendronate causes atypical femoral fractures and it is recommended that orthopedic surgeons remain vigilant in assessing their patients treated with alendronate (bisphosphonates) for osteoporosis. In such cases, alendronate should be stopped and teriparatide started. Case Report | Volume 6 | Issue 4 | JOCR September-October 2016 | Page 31-34| Rajendra Uppin, Srinath...

Read More